Moreover, the antihistamine/nanoparticulate corticosteroid compositions of the invention exhibit dramatic redispersion of the nanoparticulate corticosteroid particles upon administration to a mammal, such as a human or animal, as demonstrated by reconstitution/redispersion in a biorelevant aqueous media such that the effective average particle size of the redispersed corticosteroid particles is le